200 related articles for article (PubMed ID: 35559682)
1. FasL microgels induce immune acceptance of islet allografts in nonhuman primates.
Lei J; Coronel MM; Yolcu ES; Deng H; Grimany-Nuno O; Hunckler MD; Ulker V; Yang Z; Lee KM; Zhang A; Luo H; Peters CW; Zou Z; Chen T; Wang Z; McCoy CS; Rosales IA; Markmann JF; Shirwan H; García AJ
Sci Adv; 2022 May; 8(19):eabm9881. PubMed ID: 35559682
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice.
Yolcu ES; Zhao H; Bandura-Morgan L; Lacelle C; Woodward KB; Askenasy N; Shirwan H
J Immunol; 2011 Dec; 187(11):5901-9. PubMed ID: 22068235
[TBL] [Abstract][Full Text] [Related]
3. Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance.
Headen DM; Woodward KB; Coronel MM; Shrestha P; Weaver JD; Zhao H; Tan M; Hunckler MD; Bowen WS; Johnson CT; Shea L; Yolcu ES; García AJ; Shirwan H
Nat Mater; 2018 Aug; 17(8):732-739. PubMed ID: 29867165
[TBL] [Abstract][Full Text] [Related]
4. Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression.
Batra L; Shrestha P; Zhao H; Woodward KB; Togay A; Tan M; Grimany-Nuno O; Malik MT; Coronel MM; García AJ; Shirwan H; Yolcu ES
J Immunol; 2020 May; 204(10):2840-2851. PubMed ID: 32253240
[TBL] [Abstract][Full Text] [Related]
5. Localized immune tolerance from FasL-functionalized PLG scaffolds.
Skoumal M; Woodward KB; Zhao H; Wang F; Yolcu ES; Pearson RM; Hughes KR; García AJ; Shea LD; Shirwan H
Biomaterials; 2019 Feb; 192():271-281. PubMed ID: 30458362
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege.
Woodward KB; Zhao H; Shrestha P; Batra L; Tan M; Grimany-Nuno O; Bandura-Morgan L; Askenasy N; Shirwan H; Yolcu ES
Am J Transplant; 2020 May; 20(5):1285-1295. PubMed ID: 31850658
[TBL] [Abstract][Full Text] [Related]
7. A hydrogel platform for co-delivery of immunomodulatory proteins for pancreatic islet allografts.
Medina JD; Barber GF; Coronel MM; Hunckler MD; Linderman SW; Quizon MJ; Ulker V; Yolcu ES; Shirwan H; García AJ
J Biomed Mater Res A; 2022 Nov; 110(11):1728-1737. PubMed ID: 35841329
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation with SA-FasL protein as an effective means of preventing islet allograft rejection in chemically diabetic NOD mice.
Yolcu ES; Zhao H; Shirwan H
Transplant Proc; 2013 Jun; 45(5):1889-91. PubMed ID: 23769064
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
10. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
Fiedor P; Jin MX; Hardy MA; Oluwole SF
Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
[TBL] [Abstract][Full Text] [Related]
11. Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate.
Abdulreda MH; Berman DM; Shishido A; Martin C; Hossameldin M; Tschiggfrie A; Hernandez LF; Hernandez A; Ricordi C; Parel JM; Jankowska-Gan E; Burlingham WJ; Arrieta-Quintero EA; Perez VL; Kenyon NS; Berggren PO
Diabetologia; 2019 May; 62(5):811-821. PubMed ID: 30701283
[TBL] [Abstract][Full Text] [Related]
12. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
Li H; Colson YL; Ildstad ST
Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of PEGylated islets enhances therapeutic efficacy in a diabetic nonhuman primate model.
Stabler CL; Giraldo JA; Berman DM; Gattás-Asfura KM; Willman MA; Rabassa A; Geary J; Diaz W; Kenyon NM; Kenyon NS
Am J Transplant; 2020 Mar; 20(3):689-700. PubMed ID: 31597005
[TBL] [Abstract][Full Text] [Related]
14. The effect of epitope-based ligation of ICAM-1 on survival and retransplantation of pig islets in nonhuman primates.
Lee JI; Kim J; Choi YJ; Park HJ; Park HJ; Wi HJ; Yoon S; Shin JS; Park JK; Jung KC; Lee EB; Kang HJ; Hwang ES; Kim SJ; Park CG; Park SH
Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29131413
[TBL] [Abstract][Full Text] [Related]
15. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients.
Scharp DW; Lacy PE; Santiago JV; McCullough CS; Weide LG; Boyle PJ; Falqui L; Marchetti P; Ricordi C; Gingerich RL
Transplantation; 1991 Jan; 51(1):76-85. PubMed ID: 1987709
[TBL] [Abstract][Full Text] [Related]
16. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.
Keymeulen B; Ling Z; Gorus FK; Delvaux G; Bouwens L; Grupping A; Hendrieckx C; Pipeleers-Marichal M; Van Schravendijk C; Salmela K; Pipeleers DG
Diabetologia; 1998 Apr; 41(4):452-9. PubMed ID: 9562350
[TBL] [Abstract][Full Text] [Related]
17. Microencapsulated adult porcine islets transplanted intraperitoneally in streptozotocin-diabetic non-human primates.
Safley SA; Kenyon NS; Berman DM; Barber GF; Willman M; Duncanson S; Iwakoshi N; Holdcraft R; Gazda L; Thompson P; Badell IR; Sambanis A; Ricordi C; Weber CJ
Xenotransplantation; 2018 Nov; 25(6):e12450. PubMed ID: 30117193
[TBL] [Abstract][Full Text] [Related]
18. Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance.
Wang XY; Sun J; Wang C; France M; Sheil AG
Transplantation; 2001 Jan; 71(1):102-11. PubMed ID: 11211174
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of an iNKT cell ligand and CD40-CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients.
Kanzawa T; Hirai T; Fukuda H; Katsumata H; Ishii R; Ikemiyagi M; Ishii Y; Saiga K; Okumi M; Tanabe K
Acta Diabetol; 2019 May; 56(5):541-550. PubMed ID: 30758788
[TBL] [Abstract][Full Text] [Related]
20. Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model.
Hirshberg B; Preston EH; Xu H; Tal MG; Neeman Z; Bunnell D; Soleimanpour S; Hale DA; Kirk AD; Harlan DM
Transplantation; 2003 Jul; 76(1):55-60. PubMed ID: 12865786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
